Careers | Find us | Contact us
2025-02-28T09:34:53+00:0028 February 2025|
In celebration of Rare Disease Day, we caught up with Matt Hurles, Director and Senior Group Leader at the Wellcome Sanger Institute, to reflect on the importance of raising awareness of rare diseases and how our work at the Institute is supporting this community by accelerating our progress in the genomics space.
2025-01-24T16:34:16+00:0027 January 2025|
Global science challenges demand global solutions. Genomic data diversity and international collaboration are critical to this.
2025-01-12T08:37:47+00:0020 December 2024|
What has genetics done for us? Well in 2024, it paved the way for better cancer treatment, supported conservation efforts and mapped the hidden world of connections in our bodies to name but three. So, sit back as we unwrap eight gifts that genetics at the Sanger Institute has provided this year.
2024-12-12T13:50:41+00:0012 December 2024|
Tardigrades are tiny creatures renowned for their ability to survive extreme conditions. Dr Witold Morek, Postdoc at the Wellcome Sanger Institute, studies tardigrade genomes to unravel their evolution. This work could help enhance scientific understanding of biodiversity and lead to innovations in medicine and biotechnology.
2024-12-10T11:50:45+00:0010 December 2024|
Policy Analyst Gemma Brown talks about the role of the Sanger Institute and the Global Alliance for Genomics and Health in ensuring data is shared responsibly and that everyone has equal access to research data. She reflects on the aligned mission of Sanger and the Alliance, the challenges in data sharing and what is being done to overcome them.
2024-12-02T16:38:12+00:002 December 2024|
David Nicholson, Sanger Institute Policy and Advocacy Manager, attended this year’s United Nations biodiversity COP 16 conference. He reflects on how the agreed proposals can support equitable global genomics research.
2024-11-12T11:17:26+00:0012 November 2024|
Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.
2024-12-18T16:09:19+00:0024 October 2024|
Dr Leopold Parts, Group Leader at the Wellcome Sanger Institute, studies the effects of DNA mutations by engineering variation in cells. After almost 10 years at Sanger, he has worked across different research areas and experienced significant changes in the field of biology. We spoke with Leo to hear his vision for the role of AI in enhancing gene editing and how it may revolutionise generative and synthetic genomics.
2024-12-18T16:10:18+00:0017 October 2024|
Artificial intelligence (AI) is transforming biology by enabling researchers to build predictive models from vast biological datasets. Wellcome Sanger Institute researchers are leveraging AI tools to predict, design, and engineer biological sequences, such as DNA and proteins.
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244
